8:00 am Coffee & Networking

8:55 am Chairs Opening Remarks

Data Management & Integration in Biologics: Ensuring Quality, Security & Standardization

9:00 am Advancing Data Management & Integration Strategies for Enhanced Compliance & Efficiency in Biologics Development

• Mark Aquino Associate Director and Principal Data Scientist, Abbvie

9:30 am Data Management & Integration Strategies to Enable Continuous Feedback in Biologics Development

• Prashanth Vishwanath Director and Head Of Biologics Informatics & Automation, Takeda Pharmaceutical

10:00 am Maximizing Impact with Minimal Data: Ensuring Quality & Relevance for Effective Machine Learning in Biologics

• Goutham Mylavarapu Associate Director, Teva Pharmaceuticals

10:30 am Morning Break

11:30 am Panel Discussion: Enhancing Data Consistency in Biologics Research: Overcoming Variability & Promoting Standardization

• Yao Fan Director - Protein Design & Optimization, Tectonic Therapeutic
• Mark Aquino Associate Director and Principal Data Scientist, Abbvie
• Naresh Chennamsetty Associate Scientific Director, Bristol Myers Squibb

Computational Approaches for Enhancing Antibody Developability & Safety

12:00 pm Computational Tools for Reducing T Cell immunogenicity

• Yifan Song Chief Science Officer & Co-Founder, Cyrus Biotechnology Inc.

12:30 pm Application of Computational Tools to Address Developability-related Properties in Antibodies

• Varun Mahendra Chauhan Structural Biology & Research Scientist, Elanco Animal Health

12:50 pm OmniDeepTM: Harmonizing Deep Learning and Deep Screening

• David Mowrey Senior Manager - Modeling & Computational Design, Omniab

1:00 pm Lunch Break & Networking

2:00 pm Computational Tools to Assess Developability & Critical Quality Attributes of Biologics

• Naresh Chennamsetty Associate Scientific Director, Bristol Myers Squibb

2:30 pm Machine Learning for Antibodies Developability Assessment

• Maryam Pouryahya Associate Diretor - Data Science, AstraZeneca

Computational Innovations in the Design & Optimization of Complex Biologics

3:00 pm Advancing AAV Capsid Design: Harnessing Machine Learning for Enhanced Therapeutic Efficacy

• Peixin Zhu Vice President - Editing Discovery, Verve Therapeutics

3:30 pm Closing Remarks

3:40 pm End of Day